Delivery Order 75N93024D00017-75N93026F00002
Award Date 7/22/26
Potential Completion Date 7/14/31
Potential Value $621K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Taiwan
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on September 6, 2018, with a ceiling value of $1,797,620 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for Task A25, exercising Options A, B, and C to provide preclinical models of infectious diseases. Place of performance is St Charles, MO. The order is firm fixed price with an ultimate completion date of September 14, 2019. The delivery...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on August 12, 2022, with a ceiling value of $1,197,620, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for preclinical infectious disease research services. Place of performance is Taiwan. The order was administratively closed on August 11, 2023, with remaining funds de-obligated. The work involved designing and producing specialized animal...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 19, 2023, with a ceiling value of $1,193,205 to exercise Option 5B under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ contract for murine models of antibiotic-resistant urinary tract infection. Ultimate completion date is February 27, 2025. Place of performance is Taiwan. The order is priced on a firm fixed price basis and carries no...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on May 16, 2022, with a ceiling value of $288,577, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for preclinical infectious disease research services. Place of performance is Taiwan. The order was administratively closed on May 17, 2023, following de-obligation of remaining funds. Work under the parent IDIQ involves designing and supplying...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on September 7, 2021, with a ceiling value of $1,170,062.04, to develop preclinical models of infectious diseases. The order was issued under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ contract. Place of performance is Taiwan. The ultimate completion date is July 30, 2023. The order was priced firm fixed price with no set-aside. Service...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on August 3, 2018, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ, with a ceiling value of $1,272,675 to exercise options 1, 2, and 5 for therapeutic testing in murine models of bacterial thigh and lung infections as preclinical models of infectious diseases. Place of performance is St Charles, MO. The order is firm fixed price with an...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 9, 2020, with a ceiling value of $1,628,062, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for therapeutic testing in murine models of bacterial thigh, lung, and peritonitis infections. The order was firm fixed price. Place of performance is Taiwan. Ultimate completion date is July 31, 2021. The order was de-obligated and...
- The National Institute of Allergy and Infectious Diseases issued a $1,187,770 delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 1, 2019, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for therapeutic testing in murine models of bacterial thigh, lung, and peritonitis infections. The parent IDIQ supports preclinical infectious disease research by providing animal and animal replacement models for screening and evaluating medical countermeasures...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on June 5, 2018, with a ceiling value of $506,429, to develop murine models of lung infection caused by antibiotic-resistant Pseudomonas aeruginosa as preclinical models for infectious disease research. The order was issued under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ. Place of performance is Rockville, MD. The ultimate completion date is...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Bioqual, Inc. on March 17, 2017, with a ceiling value of $2,329,868.98 under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ. The order calls for assessment of Neisseria gonorrhea and Chlamydia trachomatis co-infection using animal models. Task C34 is a change order covering the period from August 21, 2018 through November 30, 2018. Work is performed in Rockville, Maryland. The order carries...